BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3404 related articles for article (PubMed ID: 30966861)

  • 1. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
    Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
    Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.
    Cheng J; Liao Y; Dong Y; Hu H; Yang N; Kong X; Li S; Li X; Guo J; Qin L; Yu J; Ma C; Li J; Li M; Tang B; Yuan Z
    Autophagy; 2020 Dec; 16(12):2193-2205. PubMed ID: 32003282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent autophagy.
    Di Q; Zhao X; Tang H; Li X; Xiao Y; Wu H; Wu Z; Quan J; Chen W
    Autophagy; 2023 Mar; 19(3):873-885. PubMed ID: 35900990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3.
    Cai B; Zhao J; Zhang Y; Liu Y; Ma C; Yi F; Zheng Y; Zhang L; Chen T; Liu H; Liu B; Gao C
    Autophagy; 2022 May; 18(5):990-1004. PubMed ID: 34486483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired lipophagy induced-microglial lipid droplets accumulation contributes to the buildup of TREM1 in diabetes-associated cognitive impairment.
    Li Q; Zhao Y; Guo H; Li Q; Yan C; Li Y; He S; Wang N; Wang Q
    Autophagy; 2023 Oct; 19(10):2639-2656. PubMed ID: 37204119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine Mitigated NLRP3-Mediated Neuroinflammation
    Zhang L; Xiao F; Zhang J; Wang X; Ying J; Wei G; Chen S; Huang X; Yu W; Liu X; Zheng Q; Xu G; Yu S; Hua F
    Front Pharmacol; 2021; 12():646265. PubMed ID: 34079457
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation.
    Zhu H; Xiao F; Xiao Y; Guo Y; Shan X; Zhang Z; Zhang L; Guo H
    J Neuroinflammation; 2023 Dec; 20(1):304. PubMed ID: 38110963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SQSTM1-dependent autophagic degradation of PKM2 inhibits the production of mature IL1B/IL-1β and contributes to LIPUS-mediated anti-inflammatory effect.
    Zhang B; Chen H; Ouyang J; Xie Y; Chen L; Tan Q; Du X; Su N; Ni Z; Chen L
    Autophagy; 2020 Jul; 16(7):1262-1278. PubMed ID: 31500508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy.
    Jiang H; Xie Y; Lu J; Li H; Zeng K; Hu Z; Wu D; Yang J; Yao Z; Chen H; Gong X; Yu X
    Autophagy; 2024 Jan; 20(1):76-93. PubMed ID: 37647255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
    Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
    J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer.
    Guo W; Sun Y; Liu W; Wu X; Guo L; Cai P; Wu X; Wu X; Shen Y; Shu Y; Gu Y; Xu Q
    Autophagy; 2014 Jun; 10(6):972-85. PubMed ID: 24879148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fucoidan Inhibits NLRP3 Inflammasome Activation by Enhancing p62/SQSTM1-Dependent Selective Autophagy to Alleviate Atherosclerosis.
    Cheng Y; Pan X; Wang J; Li X; Yang S; Yin R; Ma A; Zhu X
    Oxid Med Cell Longev; 2020; 2020():3186306. PubMed ID: 33505579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The macrophage-specific V-ATPase subunit ATP6V0D2 restricts inflammasome activation and bacterial infection by facilitating autophagosome-lysosome fusion.
    Xia Y; Liu N; Xie X; Bi G; Ba H; Li L; Zhang J; Deng X; Yao Y; Tang Z; Yin B; Wang J; Jiang K; Li Z; Choi Y; Gong F; Cheng X; O'Shea JJ; Chae JJ; Laurence A; Yang XP
    Autophagy; 2019 Jun; 15(6):960-975. PubMed ID: 30681394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy-dependent PELI3 degradation inhibits proinflammatory IL1B expression.
    Giegerich AK; Kuchler L; Sha LK; Knape T; Heide H; Wittig I; Behrends C; Brüne B; von Knethen A
    Autophagy; 2014; 10(11):1937-52. PubMed ID: 25483963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
    Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
    Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells.
    Huang P; Zhang Z; Zhang P; Feng J; Xie J; Zheng Y; Liang X; Zhu B; Chen Z; Feng S; Wang L; Lu J; Liu Y; Zhang Y
    Mol Neurobiol; 2024 May; 61(5):2590-2605. PubMed ID: 37917301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BECN2 (beclin 2) Negatively Regulates Inflammasome Sensors Through ATG9A-Dependent but ATG16L1- and LC3-Independent Non-Canonical Autophagy.
    Deng G; Li C; Chen L; Xing C; Fu C; Qian C; Liu X; Wang HY; Zhu M; Wang RF
    Autophagy; 2022 Feb; 18(2):340-356. PubMed ID: 34152938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy.
    Thangaraj A; Periyasamy P; Liao K; Bendi VS; Callen S; Pendyala G; Buch S
    Autophagy; 2018; 14(9):1596-1619. PubMed ID: 29966509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
    Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B
    Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 171.